But the Cystic Fibrosis Trust said the medicine was "transformational", had a "dramatic effect" and that experts say "no other medicine addresses the basic genetic defect in cystic fibrosis".
BBC: Cystic fibrosis: New drug Kalydeco refused for Welsh NHS